Literature DB >> 7535840

Herpes simplex virus encephalitis in a mouse model: PCR evidence for CNS latency following acute infection.

C W Drummond1, R P Eglin, M M Esiri.   

Abstract

We have used a mouse model of herpes simplex encephalitis produced by intranasal inoculation of virus to study the expression of viral immediate early, early and late genes and latency associated transcript (LAT) in trigeminal ganglia and brain at various times after inoculation. A PCR technique was used to detect the viral gene transcripts. All viral genes were expressed between post-inoculation days 1 and 13. On post-inoculation day 42 when the acute infection had subsided only the LAT could be detected, most commonly (70%) in the trigeminal ganglion but also, in 50% of mice, in the brain stem, in 40% in olfactory bulbs and in 20% in cerebrum and cerebellum. These findings suggest that latent infection by HSV-1 may be relatively readily established in the CNS as well as in sensory ganglia. The frequency of establishment of latency appears to be related to the neuroanatomical accessibility of each brain region to the site of entry of the virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535840     DOI: 10.1016/0022-510x(94)90068-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Olfactory transmission of neurotropic viruses.

Authors:  Isamu Mori; Yukihiro Nishiyama; Takashi Yokochi; Yoshinobu Kimura
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 2.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice.

Authors:  Lorne F Kastrukoff; Allen S Lau; Fumio Takei; Francis R Carbone; Anthony A Scalzo
Journal:  Immunol Cell Biol       Date:  2015-05-14       Impact factor: 5.126

4.  Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice.

Authors:  P Sundaresan; W D Hunter; R L Martuza; S D Rabkin
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

6.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

7.  Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo.

Authors:  Wei Wang; Cuijing Xu; Jianqiang Zhang; Jinpeng Wang; Rilei Yu; Dongping Wang; Ruijuan Yin; Wenmiao Li; Tao Jiang
Journal:  Br J Pharmacol       Date:  2020-01-23       Impact factor: 8.739

8.  The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).

Authors:  Lorne F Kastrukoff; Allen S Lau; Eva E Thomas
Journal:  Herpesviridae       Date:  2012-03-26

9.  Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon hispidus.

Authors:  Marina S Boukhvalova; Emma Mortensen; Aissatou Mbaye; Diego Lopez; Lorne Kastrukoff; Jorge C G Blanco
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.